Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations

103Citations
Citations of this article
89Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There is currently great interest in the use of mesenchymal stem/stromal cells (MSCs) for the therapy of many diseases of animals and humans. However, we are still left with the serious challenges in explaining the beneficial effects of the cells. Hence, it is essential to work backward from dramatic results obtained in vivo to the cellular and molecular explanations in order to discover the secrets of MSCs. This review will focus on recent data that have changed the paradigms for understanding the therapeutic potentials of MSCs. © 2011 Wiley Periodicals, Inc. © 2011 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Prockop, D. J., & Oh, J. Y. (2012). Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations. Journal of Cellular Biochemistry, 113(5), 1460–1469. https://doi.org/10.1002/jcb.24046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free